Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways.
Quick Facts
What This Study Found
Tβ4 significantly suppressed the activation of the NLRP3 inflammasome and related inflammatory markers.
Key Numbers
How They Did This
The study used RAW 264.7 and LX-2 cells, priming them with LPS and stimulating with ATP to activate the NLRP3 inflammasome, while assessing the effects of Tβ4.
Why This Research Matters
This research highlights a potential therapeutic role for Tβ4 in managing liver inflammation and fibrosis, which are common issues in various liver diseases.
What This Study Doesn't Tell Us
The study was conducted in vitro, so results may not directly translate to human conditions.
Trust & Context
- Original Title:
- Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways.
- Published In:
- International journal of molecular sciences, 24(4) (2023)
- Authors:
- Choi, Jihye, Cho, Yunsang, Choi, Hwal, Lee, Sangmin, Han, Hyeju, Lee, Jeonghyeon, Kwon, Jungkee
- Database ID:
- RPEP-06800
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06800APA
Choi, Jihye; Cho, Yunsang; Choi, Hwal; Lee, Sangmin; Han, Hyeju; Lee, Jeonghyeon; Kwon, Jungkee. (2023). Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways.. International journal of molecular sciences, 24(4). https://doi.org/10.3390/ijms24043439
MLA
Choi, Jihye, et al. "Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellate Cells via the Regulation of Multiple Signaling Pathways.." International journal of molecular sciences, 2023. https://doi.org/10.3390/ijms24043439
RethinkPeptides
RethinkPeptides Research Database. "Thymosin Beta 4 Inhibits LPS and ATP-Induced Hepatic Stellat..." RPEP-06800. Retrieved from https://rethinkpeptides.com/research/choi-2023-thymosin-beta-4-inhibits
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.